New TGA Update on GLP-1 Medicines with Rare Eye Disease Warning (A Surry Hills Doctors Update)
TGA (Therapeutic Goods Administration) GLP-1 Eye Safety Update: What Patients Need to Know The Therapeutic Goods Administration (TGA) has announced an important class-wide safety update for GLP-1 receptor agonists (GLP-1 RAs) following international reviews of emerging evidence... READ MORE

